Signaling Pathways - Calcium-Activated Potassium (KCa) Channels - KDM - adrenoceptor - Leukotriene and Related Receptors
清除全部
- B4930 TC-E 5002Target: KDMSummary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
- B6552 CGP 20712 dihydrochlorideTarget: adrenoceptorSummary: β1拮抗剂
- B7023 MK-571Target: Leukotriene and Related ReceptorsSummary: leukotriene D4(LTD4)受体拮抗剂
- B2191 Dequalinium Chloride中文名: 地喹氯铵Target: PKC|Calcium-Activated Potassium (KCa) ChannelsSummary: PKC抑制剂
- B2068 Zafirlukast中文名: 扎鲁司特Target: Leukotriene and Related ReceptorsSummary: 口服白三烯受体拮抗剂
- A8474 Mirabegron (YM178)中文名: 米拉贝隆Target: adrenoceptorSummary: 选择性β3肾上腺素受体激动剂
- A5354 Zonisamide中文名: 唑尼沙胺Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|Carbonic Anhydrases|Calcium-Activated Potassium (KCa) ChannelsSummary: 抗惊厥和机械效应的抗癫痫药
- A1888 TRAM-34Target: Calcium-Activated Potassium (KCa) ChannelsSummary: KCa3.1阻断剂
- A3348 Daminozide中文名: 丁酰肼Target: KDM|PHFSummary: KDM2A抑制剂